Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV vaccine immune response in HIV-positive men
RBR-4c7pd5Recruiting
- Sponsor
- Infant Care
- Start
- Jul 2017
- Countries
- 1
01
Overview
Open-label trial of quadrivalent human papillomavirus vaccine in human papillomavirus infection (2 arms), sponsored by Infant Care. Primary endpoint: Protective antibody response after HPV vaccination. Started Jul 2017; status: recruiting.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on RBR-4c7pd5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4c7pd5.